| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537823 | Pulmonary Pharmacology & Therapeutics | 2018 | 21 Pages |
Abstract
The combination of glucocorticoids with LABA counteracts the pathologic metabolism of HA in patients with COPD, suggesting an additional beneficial effect of the drugs when used for the treatment of COPD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Eleni Papakonstantinou, Ioannis Klagas, George Karakiulakis, Michael Tamm, Michael Roth, Daiana Stolz,